CNGT logo

Cannagistics, Inc. (CNGT) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cannagistics, Inc. (CNGT) opera en el sector Financial Services, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 44/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 44/100

Cannagistics, Inc. (CNGT) Perfil de Servicios Financieros

CEOJames W. Zimbler
Empleados1
Sede CentralHauppauge, US
Año de la oferta pública inicial (OPI)2006

Cannagistics, Inc., operating within the financial services sector as a shell company, focuses on developing and marketing a diverse portfolio of OTC, pharmaceutical, and nutraceutical products. Its offerings span health and wellness categories, distributed through various channels, positioning it within the competitive landscape of consumer health products.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Cannagistics, Inc. presents a high-risk, high-reward investment profile given its OTC listing and limited financial information. The company's diverse product portfolio, ranging from nutraceuticals to agricultural products, offers potential revenue streams, but also introduces operational complexity. With a market capitalization of $0.00 billion and a negative P/E ratio, the company's financial performance requires careful scrutiny. The beta of 3.28 indicates high volatility compared to the market. Potential catalysts include successful product launches and expansion into new markets, but these are speculative. Investors should conduct thorough due diligence, focusing on the company's financial disclosures, revenue generation, and competitive positioning. The company's reliance on wholesale, retail, and e-commerce channels exposes it to market fluctuations and competitive pressures.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.00 billion, indicating a micro-cap company with limited financial resources.
  • Negative P/E ratio, reflecting the company's current lack of profitability.
  • Beta of 3.28, suggesting high volatility compared to the overall market.
  • No dividend yield, indicating that the company is not currently returning capital to shareholders.
  • Operates with a single employee, highlighting the company's limited operational scale.

Competidores y Pares

Fortalezas

  • Diverse product portfolio across multiple health and wellness categories.
  • Distribution network encompassing wholesale, retail, and e-commerce channels.
  • Proprietary formulations for select products.
  • Established presence in niche market segments.

Debilidades

  • Limited financial resources and market capitalization.
  • Dependence on a small number of employees.
  • Lack of profitability and negative P/E ratio.
  • High beta indicating significant volatility.

Catalizadores

  • Ongoing: Expansion of product distribution through e-commerce platforms.
  • Ongoing: Development and launch of new health and wellness products.
  • Ongoing: Strategic partnerships with retail chains.
  • Upcoming: Potential for increased brand awareness through marketing initiatives.
  • Upcoming: Possible acquisitions or mergers to expand market share.

Riesgos

  • Potential: Limited financial resources and market capitalization.
  • Potential: Dependence on a small number of employees.
  • Ongoing: Intense competition from larger, more established companies.
  • Ongoing: Evolving consumer preferences and market trends.
  • Potential: Regulatory scrutiny and compliance requirements.

Oportunidades de crecimiento

  • Growth opportunity 1: Expansion of e-commerce presence: Cannagistics can capitalize on the growing e-commerce market by enhancing its online sales channels. The global e-commerce market is projected to reach trillions of dollars by 2026. By investing in its online platform, improving its digital marketing strategies, and offering competitive pricing, Cannagistics can attract a wider customer base and increase its sales volume. This strategy requires investment in technology and logistics, but offers the potential for significant revenue growth.
  • Growth opportunity 2: Strategic partnerships with retail chains: Cannagistics can pursue partnerships with major retail chains to increase its product distribution. Securing shelf space in established retail stores would provide access to a larger customer base and enhance brand visibility. This strategy requires negotiating favorable terms with retailers and ensuring consistent product supply. The timeline for establishing such partnerships could range from several months to a year, depending on the negotiation process and retailer requirements.
  • Growth opportunity 3: Development of innovative products: Cannagistics can invest in research and development to create new and innovative products that address unmet consumer needs. Focusing on emerging trends in health and wellness, such as personalized nutrition and natural remedies, could provide a competitive edge. The timeline for developing and launching new products can vary depending on the complexity of the product and regulatory requirements, but typically ranges from one to three years.
  • Growth opportunity 4: Geographic expansion into new markets: Cannagistics can expand its operations into new geographic markets, both domestically and internationally. Identifying regions with strong demand for its products and establishing distribution networks in those areas could drive revenue growth. This strategy requires careful market research and adaptation of products to local preferences. The timeline for geographic expansion can vary depending on the target market and regulatory requirements, but typically ranges from one to two years.
  • Growth opportunity 5: Leveraging veterinary and agricultural products: Cannagistics can further develop and market its products for veterinary and agricultural use. The market for animal health and agricultural products is substantial, offering opportunities for diversification and revenue growth. By focusing on innovative solutions for animal care and crop enhancement, Cannagistics can tap into these growing markets. The timeline for developing and marketing these products can vary depending on regulatory requirements and market acceptance, but typically ranges from one to two years.

Oportunidades

  • Expansion of e-commerce presence to reach a wider customer base.
  • Strategic partnerships with retail chains to increase product distribution.
  • Development of innovative products to address unmet consumer needs.
  • Geographic expansion into new markets, both domestically and internationally.

Amenazas

  • Intense competition from larger, more established companies.
  • Evolving consumer preferences and market trends.
  • Regulatory scrutiny and compliance requirements.
  • Economic downturns affecting consumer spending.

Ventajas competitivas

  • Diverse product portfolio spanning multiple health and wellness categories.
  • Proprietary formulations for certain products, such as Canagel.
  • Distribution network encompassing wholesale, retail, and e-commerce channels.
  • Established brand presence in select market segments.

Acerca de CNGT

Cannagistics, Inc., formerly known as Precious Investments, Inc., underwent a name change in May 2019, marking a shift in its business focus. Incorporated in 2004 and based in Hauppauge, New York, the company develops, markets, and sells a range of over-the-counter (OTC), pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. Cannagistics also offers IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. These products target various consumer needs, including pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. The company also provides products for veterinary and agricultural use, expanding its reach beyond human consumers. Cannagistics distributes its products through a mix of wholesale and retail channels, including brick and mortar stores and e-commerce platforms, aiming to reach a broad customer base.

Qué hacen

  • Develops over-the-counter (OTC) products.
  • Markets pharmaceutical products.
  • Sells nutraceutical products.
  • Offers cosmetic products.
  • Provides health and wellness products.
  • Distributes products through wholesale channels.
  • Sells products through retail establishments.
  • Utilizes e-commerce platforms for sales.

Modelo de Negocio

  • Develops and manufactures a range of health and wellness products.
  • Sells products through wholesale distribution to retailers.
  • Markets products directly to consumers through e-commerce platforms.
  • Generates revenue through product sales.

Contexto de la Industria

Cannagistics, Inc. operates within the shell companies industry, a segment of the financial services sector characterized by companies with limited operations and often speculative ventures. The market for OTC, pharmaceutical, nutraceutical, and cosmetic products is highly competitive, with established players and evolving consumer preferences. Cannagistics' success depends on its ability to differentiate its products, establish effective distribution channels, and manage its operations efficiently. The company faces competition from larger, more established companies with greater resources and brand recognition. The industry is also subject to regulatory scrutiny and evolving consumer trends, requiring companies to adapt and innovate to maintain their market position.

Clientes Clave

  • Retail consumers seeking health and wellness products.
  • Wholesale distributors and retailers.
  • Veterinary and agricultural customers.
  • Online shoppers.
Confianza de la IA: 79% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Cannagistics, Inc. (CNGT): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para CNGT.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CNGT.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CNGT.

MoonshotScore

44/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CNGT en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: James W. Zimbler

Managing

James W. Zimbler serves as the managing executive of Cannagistics, Inc. Information regarding Mr. Zimbler's detailed career history, educational background, and previous roles is not available in the provided data. His leadership is central to the company's strategic direction and operational execution. As managing executive, he oversees all aspects of the company's business, from product development and marketing to sales and distribution.

Historial: Due to limited information, James W. Zimbler's specific achievements and strategic decisions at Cannagistics, Inc. cannot be fully assessed. The company's performance and milestones under his leadership require further evaluation based on available financial and operational data. His tenure is marked by the company's focus on developing and marketing a diverse range of health and wellness products.

Información del mercado OTC de CNGT

The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannagistics, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries significant risks due to the potential for limited information and higher volatility. These stocks are typically more speculative and require a higher degree of due diligence.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Given that Cannagistics, Inc. trades on the OTC Other tier, liquidity is likely limited. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Low trading volume can also lead to price volatility and potential difficulties in executing large trades. Investors should be prepared for potential delays and price fluctuations when trading CNGT shares.
Factores de riesgo OTC:
  • Limited financial disclosure and transparency.
  • Potential for low trading volume and liquidity.
  • Higher price volatility compared to exchange-listed stocks.
  • Increased risk of fraud or manipulation.
  • Limited regulatory oversight and investor protection.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if available).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's revenue generation and profitability.
  • Review the company's legal and regulatory compliance.
  • Monitor trading volume and price volatility.
  • Consult with a qualified financial advisor.
Señales de legitimidad:
  • Company's incorporation date (2004) suggests some operating history.
  • Presence of a physical headquarters in Hauppauge, New York.
  • Development and marketing of a range of health and wellness products.
  • Active website and online presence (if available).
  • Independent third-party verification of product claims (if available).

Preguntas Comunes Sobre CNGT

¿Cuáles son los factores clave para evaluar CNGT?

Cannagistics, Inc. (CNGT) actualmente tiene una puntuación IA de 44/100, indicando puntuación baja. Fortaleza clave: Diverse product portfolio across multiple health and wellness categories.. Riesgo principal a monitorear: Potential: Limited financial resources and market capitalization.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CNGT?

CNGT actualmente puntúa 44/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CNGT?

Los precios de CNGT se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CNGT?

La cobertura de analistas para CNGT incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CNGT?

Las categorías de riesgo para CNGT incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Limited financial resources and market capitalization.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CNGT?

La relación P/E para CNGT compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CNGT sobrevalorada o infravalorada?

Determinar si Cannagistics, Inc. (CNGT) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CNGT?

Cannagistics, Inc. (CNGT) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited financial information available for Cannagistics, Inc.
  • OTC stocks are inherently more risky than exchange-listed stocks.
  • AI analysis pending for CNGT.
Fuentes de datos

Popular Stocks